Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Marsland

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Oncology Practice|January 29, 2015
Admission versus observation: clinically impactful or just a reimbursement shell game?Thomas Marsland
The Journal of Family Practice|December 18, 2002
Maternal screening strategy more effective than risk-based approaches for preventing group B streptococcal disease in neonatesThomas Marsland, Valerie King
Case Reports in Oncology|May 8, 2014
Circulating tumor cell data: integration with imaging and serum tumor markers for metastatic breast cancer patient managementThomas Marsland, Eric R Schuur
Journal of Oncology Practice|February 14, 2018
News and Notes From the 2009 Carrier Advisory Committee Meeting: Medical Necessity, Off-Label Chemotherapy, and MoreBarbara McAneny, Thomas Marsland, Kristen King
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
The NCI Community Oncology Research Program: what every clinician needs to knowWorta McCaskill-Stevens, Alan P Lyss, Marge Good, et al.
Clinical Breast Cancer|June 12, 2002
Phase II trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: preliminary resultsJoyce O'Shaughnessy, Svetislava J Vukelja, Thomas Marsland, et al.
Journal of Oncology Practice|January 4, 2011
Reducing cancer costs and improving quality through collaboration with payers: a proposal from the Florida society of clinical oncologyThomas Marsland, Gerald Robbins, Alan Marks, et al.
Clinical Breast Cancer|July 13, 2004
Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancerJoyce A O'Shaughnessy, Sasha Vukelja, Thomas Marsland, et al.
Oncology (Williston Park, N.Y.)|January 11, 2012
Perspective on...the new PSA screening recommendationsThomas Marsland, Francis Arena, Alan Yeilding, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS)Fairooz Kabbinavar, Louis Fehrenbacher, John Hainsworth, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Oncology Practice|January 29, 2015
Admission versus observation: clinically impactful or just a reimbursement shell game?Thomas Marsland
The Journal of Family Practice|December 18, 2002
Maternal screening strategy more effective than risk-based approaches for preventing group B streptococcal disease in neonatesThomas Marsland, Valerie King
Case Reports in Oncology|May 8, 2014
Circulating tumor cell data: integration with imaging and serum tumor markers for metastatic breast cancer patient managementThomas Marsland, Eric R Schuur
Journal of Oncology Practice|February 14, 2018
News and Notes From the 2009 Carrier Advisory Committee Meeting: Medical Necessity, Off-Label Chemotherapy, and MoreBarbara McAneny, Thomas Marsland, Kristen King
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
The NCI Community Oncology Research Program: what every clinician needs to knowWorta McCaskill-Stevens, Alan P Lyss, Marge Good, et al.
Clinical Breast Cancer|June 12, 2002
Phase II trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: preliminary resultsJoyce O'Shaughnessy, Svetislava J Vukelja, Thomas Marsland, et al.
Journal of Oncology Practice|January 4, 2011
Reducing cancer costs and improving quality through collaboration with payers: a proposal from the Florida society of clinical oncologyThomas Marsland, Gerald Robbins, Alan Marks, et al.
Clinical Breast Cancer|July 13, 2004
Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancerJoyce A O'Shaughnessy, Sasha Vukelja, Thomas Marsland, et al.
Oncology (Williston Park, N.Y.)|January 11, 2012
Perspective on...the new PSA screening recommendationsThomas Marsland, Francis Arena, Alan Yeilding, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS)Fairooz Kabbinavar, Louis Fehrenbacher, John Hainsworth, et al.
Pageof 2